The ANKRD30A gene is most active in breast tissue, where it appears to help breast cells keep their usual identity and pattern of activity. This gene plays an important role in how certain breast cells mature, and changes in its activity have been linked with some breast cancers. If it does not work as expected, those cells may act less like normal breast tissue, which can help doctors classify some tumors.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which do the work inside cells. Other genes mainly control when certain processes happen, where they occur, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. If you want to go further into this topic, you can find more in the LearnHub.
Overview
ANKRD30AGene function
What if the gene works
In normal tissue, the ANKRD30A gene is active mainly in breast cells. It likely helps breast cells keep their usual identity and mature in an orderly way.
Risk
What if the gene does not work
Variants in the ANKRD30A gene can reduce, alter, or stop production of the ANKRD30A protein. Milder variants may leave some protein function, while more severe variants can lead to little or no protein in the cells that normally make it.
Treatment
What does that mean for your treatment
No treatment or drug choice is currently guided by a pathogenic or loss-of-function variant in the ANKRD30A gene. The ANKRD30A gene is mainly being studied as a tumor biomarker and possible immunotherapy target, especially in breast cancer.
Gene function
What if the gene works
ANKRD30A is most active in breast tissue, especially in cells with a mature breast-cell pattern. Its protein supports the usual identity and coordinated activity of these cells. This helps explain the ANKRD30A gene's role in normal breast tissue.
ANKRD30A is made mainly in mature breast lining cells, where it is part of the cells' usual protein pattern. This supports normal breast-cell identity and routine cell activity.
Its protein has repeated sections that are commonly used to connect with other proteins. These links help cells organize routine tasks in a coordinated way.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. Sometimes, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the ANKRD30A gene can change the protein’s shape, stability, or how well it interacts with other parts of the cell. Some variants also disrupt splicing, which can lead to too little protein being made or to a shortened protein. This is one way ANKRD30A gene variants affect protein function: milder variants may partly reduce activity, while more severe variants can leave little or no working protein.
How variants are linked to conditions
At this time, the ANKRD30A gene does not yet have a broadly confirmed link to a specific health condition, though research may clarify how ANKRD30A gene variants are linked to conditions in the future. If you carry a reported change in this gene, your doctor or genetic counselor can place that result in context with your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well characterized variant in a particular gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to ANKRD30A. Anyone with concerns about personal or family risk should speak with a doctor or genetic counselor.
Inheritance of ANKRD30A variants
There is not yet a broadly confirmed Mendelian pattern for how ANKRD30A gene variants are inherited in relation to a specific human condition, so the answer to how ANKRD30A gene variants are inherited is still evolving. The ANKRD30A gene is located on chromosome 10, which is an autosome. That means each person usually inherits one copy of this gene from each parent, regardless of sex.
What does my ANKRD30A result mean for my family?
There is not yet a broadly confirmed inherited pattern linking ANKRD30A to a specific genetic condition in families, though this can change as research grows. If you have a specific ANKRD30A result, a doctor or genetic counselor can help explain what it may mean for close relatives based on the exact finding and your family history.
Genetic information
Genetic testing
How you find out about variants
To look for variants, ANKRD30A genetic testing uses a blood sample, saliva, or a cheek swab to read the DNA sequence of the ANKRD30A gene and compare it with a reference sequence. A lab then classifies any change using established evidence, such as whether it is benign, uncertain, or more likely to affect health.
When should I consider getting a genetic test?
There is not yet a broadly established ANKRD30A-specific clinical reason for routine genetic testing. Testing decisions are best made with a doctor or genetic counselor, based on your personal health history, family history, and the specific reason testing is being considered.
A genetic result is only one part of your health story
Genetic results can be informative, but what they reveal depends on the condition and on the kind of variant involved. How your body functions over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, particularly those affected by many genes, genetic information offers context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result may give a clear answer. For medication response, genetic results can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the bloodstream, or responds to it at its target. This helps explain why the same medication may work well for one person, work less well for another, or cause more side effects in someone else. These differences are common and are one part of why treatment response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics is the area of study focused on how genetic differences affect a person’s response to medications. It examines connections between genes and drugs to better explain why the same treatment can work differently from one person to another. For many medicines, genes help shape both how strongly a drug works and how the body processes it. This understanding can support more informed and more individualized treatment decisions. To explore this subject further, you can learn more in the LearnHub.
Drugs influenced by the ANKRD30A gene
When should I seek medical advice?
There is no broadly confirmed role for this gene in guiding medication response at this time, so questions about side effects, new symptoms, or how your medicines may affect you are best discussed with your doctor or pharmacist.
History
ANKRD30A first drew attention in the early 2000s, when researchers studying breast tissue and breast cancers described a gene known as NY-BR-1. It was identified through efforts to find genes with distinctive expression patterns in tumors, especially breast tumors. From these first observations, research expanded steadily, and the gene was later cataloged under the official name the ANKRD30A gene as human gene naming became more standardized. Interest in the ANKRD30A gene grew in cancer pathology because its expression pattern helped researchers distinguish certain tumor types. Its history is mainly tied to laboratory and diagnostic research rather than public awareness, but it remains a recognized part of the story of breast cancer gene discovery.